OXGENE’s technology platforms and expert solutions accelerate the discovery, development and manufacture of cell and gene therapies. We offer viral technologies for license, as well as custom solutions and cell line engineering services to meet the manufacturing demands of new cell and gene therapies. Our self-labelling integral membrane mammalian display system is the only platform that allows rapid identification and characterisation of antibodies against complex membrane proteins in their native configuration in mammalian cells.